Powerpack

Unlock full stockrow access for only $7.9/month and boost yourself as an investor.

Watchlist

Keep track of companies that you follow and research.

10 Years of Data

Full access to our data with predictions and indicators that we calculate daily.

Screener

Full access to our screener with tons of custom values and customizable email notifications.

XLS Exports

Excel export of financials and screeners you define and save.

Sixth Street Specialty Lending, Inc. TSLX

Analyst’s Commentary of Sixth Street Specialty Lending, Inc. (TSLX) Performance

Sixth Street Specialty Lending, Inc. (TSLX), a business development company (BDC) specializing in debt and equity investments in U.S. middle-market firms, presents a profile of resilient growth tempered by the inherent cyclicality of its sector. Over the past decade, TSLX has demonstrated robust revenue expansion, rising from $192 million in 2016 to a peak of $483 million in 2024—a compound annual growth rate of roughly 12%—fueled by portfolio expansion and favorable lending spreads. However, this progress has not been linear, with notable dips in profitability during periods of market stress, such as the 2020 COVID-19 downturn and the 2022 Federal Reserve rate-hiking cycle. These events underscore the BDC model’s sensitivity to economic cycles, where credit quality and borrowing costs can swing valuations dramatically. Today, with shares trading at levels that embed a forward P/E around 10x based on consensus earnings estimates, TSLX appears reasonably positioned for cautious investors eyeing income generation, though leverage risks and softening revenue projections warrant vigilance.

Historical Revenue and Profitability Trajectory

TSLX’s revenue trajectory reflects the steady deployment of capital into senior secured loans, a hallmark of BDC stability. From 2016’s $192 million baseline, revenues climbed to $271 million by 2020 (41% cumulative growth), then accelerated post-pandemic to $438 million in 2023 and $483 million in 2024 (10% year-over-year jump). This growth correlates tightly with share count expansion—from 58.6 million to 92 million—a 57% dilution that has moderated per-share metrics but supported scale. Revenue per share peaked at $5.24 in 2024, up from $3.28 in 2016 (60% increase), highlighting efficient portfolio management.

Profitability, tracked via earnings before taxes (EBT) and net income, has been more volatile. EBT margins hovered in the mid-50% range through 2019 (e.g., 56.2% in 2018), dipping to 45.4% in 2023 amid higher funding costs before stabilizing at 46.4% in 2024. Net income followed suit, surging to $212 million in 2021 (a 19% rise from 2020’s $178 million) before plunging 49% to $108 million in 2022—likely tied to non-accrual loans and mark-downs during the bear market. Recovery was swift, with 2023’s $222 million (105% rebound) underscoring TSLX’s defensive positioning in first-lien debt. Earnings per share (EPS) mirrored this, averaging $2.20 over the decade but dipping to $1.38 in 2022. These swings emphasize EBT margin’s role as a leading indicator of credit health in BDCs; sustained above 45% signals portfolio resilience, while sub-50% flags potential covenant breaches or refinancing pressures.

Book value per share (BVPS) has trended steadily upward, from $16.25 in 2016 to $17.47 in 2024 (7% cumulative gain), with minimal erosion even in down years. This stability—rare in leveraged lending—bolsters ROE, which averaged 13.5% but spiked to 17.4% in 2021 on high spreads. ROE’s importance here cannot be overstated: for BDCs, it measures equity holders’ return after debt servicing, directly impacting dividend sustainability (TSLX has maintained a high-yield payout, though specifics aren’t detailed).

Stock price action has loosely tracked these fundamentals but amplified sector beta. Lows plummeted to $11.25 in 2020 (COVID flight-to-safety rout, down 50% from 2019 highs), while highs crested $24.74 in 2021 amid recovery euphoria. By 2024, lows of $19.50 and highs of $22.35 suggest consolidation around BVPS, with P/B ratios stable at 1.1-1.3x—a premium justified by 100% gross margins (typical for fee-light lending) but vulnerable to rate normalization.

Leverage and Cash Flow Dynamics

Debt levels tell a cautionary tale of ambition meeting reality. Total debt ballooned from $681 million in 2016 to $2.3 billion in 2022 (238% increase, or 28% CAGR), coinciding with share issuance to fund growth. A deleveraging ensued, dropping 22% to $1.78 billion in 2023 and rising modestly to $1.90 billion in 2024. Net debt followed, peaking at $2.27 billion in 2022. For BDCs, leverage (here ~1.2x equity) is regulated under 1940 Act rules requiring 150-200% asset coverage, making total debt a barometer of expansion capacity—high levels amplified 2022’s ROE drop to 8.3% as interest expenses bit.

Cash flows reveal operational lumpiness. Operating cash flow swung wildly: positive $119 million in 2018, then negative $378 million in 2019 (prepay surprises?), recovering to $145 million in 2020 before multi-year negatives totaling over $700 million through 2024. Free cash flow per share echoed this, averaging negative recently (-$0.49 in 2024). Such volatility stems from BDC illiquidity—principal repayments and exits drive inflows—correlating inversely with stock lows (e.g., 2020 positivity preceded price bottom). EV/FCF multiples are erratic (negative in down years), underscoring why investors favor dividend yield over growth narratives.

Valuation Metrics in Context

At current levels, TSLX trades at a forward P/E of approximately 10x, in line with historical medians (7.9x to 13.2x) and peer BDCs. P/S has compressed to 4.1x from 5.6x in 2016, reflecting scale efficiencies, while P/B at 1.2x hugs fair value given ROIC of 4% (stable but unexciting). EV/Sales at 9.7x in 2024 (down from 10.7x early on) implies moderate growth pricing. These ratios historically bottomed during stress (e.g., 2020 P/E ~8x), rallying with EPS recovery— a pattern suggesting undervaluation if credit stabilizes.

Compared to fundamentals, stock performance lagged revenue gains: cumulative revenue +151% since 2016, yet price range implies flat-to-modest appreciation amid dilution. This divergence highlights BDC “yield traps”—high dividends (implied by EPS coverage) attract income chasers, but capital appreciation hinges on NAV growth.

Insider Activity and Market Signals

Recent insider transactions offer no fresh insights, with zero buys or sells across 2025-2026 months. In a sector where management alignment via ownership is prized, this silence is neutral—not alarming given TSLX’s external management by Sixth Street Partners (formerly Owens & Co.), which mitigates direct insider trading noise. Historically, BDC insiders buy during dislocations (e.g., post-2020), so dormancy aligns with stable markets but lacks bullish conviction.

Analyst Projections and Future Outlook

Analysts project a revenue plateau: $443 million in 2025 (-8% from 2024), $408 million in 2026 (-8%), rebounding to $412 million in 2027 (+1%). Net income holds steady at $189 million (2025), $173 million (2026, -8%), and $179 million (2027, +4%), yielding EPS of ~$1.99, $1.99, and $1.92—minimal growth after dilution to 94.5 million shares. BVPS edges to $17.36 (2025) then $17.55 (2026), supporting ROA/ROE in the 5-6%/12% band. These imply maturing portfolios, potential non-accruals from economic softening, or conservative dividend reinvestment.

Price targets embed optimism: low at ~9% above recent close, mean ~20% upside, high ~30%. This consensus (tight range) anticipates steady yields amid Fed cuts, but risks abound—recession could mirror 2022’s income plunge. Longer-term, TSLX benefits from Sixth Street’s 2021 rebrand (post-Owl Rock merger echoes, enhancing distribution) and middle-market tailwinds, though competition from private credit erodes spreads.

Strategic Considerations and Risks

Drawing historical parallels, TSLX evokes pre-2008 BDCs like Ares Capital, thriving on illiquidity premiums but humbled by cycles. The 2022 debt spike parallels 2019’s leverage push, both preceding cash flow troughs. Positively, ROIC stability (4%) exceeds cost of debt (implied ~5-6%), preserving margins.

Risks loom: persistent negative FCF signals payout pressures (dividends consume earnings), while net debt at $1.87 billion leaves little buffer if defaults rise (portfolio yield compression post-rates peak). Geopolitics—Ukraine war inflating energy costs—or U.S. slowdown could echo 2020’s low.

In sum, TSLX merits a hold for yield-oriented portfolios, with entry below BVPS. Upside to analyst means requires execution on projections; downside protected by regulation but capped by leverage. Patient accumulation suits this veteran play in specialty finance.

(Word count: 1,128)

© 2016–2026 stockrow.com Terms and Conditions Indicators Contact Us